Skip to main content

Peer Review reports

From: The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials

Original Submission
25 Apr 2014 Submitted Original manuscript
25 Apr 2014 Author responded Author comments - Fei Ma
Resubmission - Version 2
25 Apr 2014 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
23 Aug 2014 Author responded Author comments - Fei Ma
9 Jul 2014 Reviewed Reviewer Report - Ingrid Garajova'
24 Jul 2014 Reviewed Reviewer Report - Marta Castiglia
Resubmission - Version 4
23 Aug 2014 Submitted Manuscript version 4
2 Sep 2014 Author responded Author comments - Fei Ma
Resubmission - Version 5
2 Sep 2014 Submitted Manuscript version 5
Publishing
9 Sep 2014 Editorially accepted
19 Sep 2014 Article published 10.1186/1471-2407-14-683

You can find further information about peer review here.

Back to article page